Related by context. Frequent words. (Click for all words.) 60 unresectable 57 HGS ETR1 56 metastatic renal cell carcinoma 56 B CLL 56 liver metastases 55 refractory multiple myeloma 55 IMGN# 55 resistant ovarian cancer 54 squamous 54 castration resistant prostate cancer 54 NSCLC 54 AP# [003] 54 HRPC 54 evaluable patients 54 antitumor activity 54 nilotinib 54 chronic lymphocytic leukemia CLL 53 tumor shrinkage 53 HCV infected 53 evaluable 53 advanced NSCLC 53 vandetanib 52 elagolix 52 hormone refractory prostate cancer 52 GRN#L 52 imetelstat 52 TORISEL 51 neoplasia 51 Phase 1b clinical 51 androgen independent 51 temozolomide 51 GVAX 51 Cell Lung Cancer 51 CA4P 51 gefitinib 51 PXD# 51 Taxotere ® 51 adjuvant therapy 51 randomized controlled clinical 51 hepatocellular carcinoma HCC 51 tumor recurrence 51 dasatinib 51 relapsing remitting multiple sclerosis 51 bone metastasis 51 Phase IIa trial 50 genotypic 50 tumor regression 50 chronic HCV 50 brain metastases 50 HER2 negative 50 MGCD# [001] 50 FTY# 50 Her2 50 sunitinib 50 metastatic colorectal cancer 50 azacitidine 50 temsirolimus 50 tyrosine kinase inhibitors 50 phase IIb 50 lupus nephritis 50 ASA# 49 biologic therapy 49 Phase 2a trial 49 adenocarcinomas 49 systemic lupus erythematosus SLE 49 solid tumors 49 XL# [003] 49 Secondary endpoints 49 MDV# 49 hematological cancers 49 GvHD 49 hematologic malignancies 49 T DM1 49 INCB# [002] 49 CYT# 49 EORTC 49 Phase 2a clinical 49 FOLFOX 49 ALCL 48 vicriviroc 48 follicular lymphoma 48 Perifosine 48 renal cell carcinoma 48 blinatumomab 48 Cotara 48 cutaneous T cell 48 PF # [001] 48 trastuzumab 48 Torisel 48 raltegravir 48 Phase 2b clinical 48 soft tissue sarcoma 48 Bevacizumab 48 chronic myeloid leukemia CML 48 Phase IIa clinical 48 DLBCL 48 Gemcitabine 48 bortezomib 48 metastatic 48 distant metastases 48 Phase Ib